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Volume 53, Number 17S Abstracts 85SResults: There was 100% procedural success in 16
injury sites treated with adventitial injections. NAB rapa-
mycin treated vessels had significantly larger lumen
(p0.01, ANOVA) and total vessel areas (p0.005) indi-
cating less negative remodeling. Percent luminal stenosis
and maximal intimal width decreased in a dose-dependent
fashion.Control vessels had significantly more fibrosis
(p0.001).
Conclusions: These data suggest that adventitial deliv-
ery of rapamycin decreases luminal stenosis by inhibiting
IH and preventing negative remodeling.The decreased fi-
brosis in treated vessels suggests a mechanism by which
rapamycin may affect vessel remodeling.
Mean values for measured and calculated metrics for 16
injured femoral segments treated with adventitial
injection of vehicle or NAB rapamycin.
vehicle
5 g
rapamycin
500 g
rapamycin p-value
Lumen area (mm2) 3.35 5.18 3.81 p0.01
Total vessel area
(mm2) 7.36 9.90 8.33 p0.005
Max initimal width
(mm) 0.23 0.20 0.12 NS
Intima/Media ratio 0.17 0.16 0.11 NS
Percent luminal
stenosis 19.5% 17.3% *11.4% p.01
Fibrosis score 1.78 1.76* 0.68* p0.0001
Inflammation score 1.09 1.21 1.13 NS
Author Disclosures: M. S. Conte: Nothing to disclose;
W. J. Gasper: Nothing to disclose; C. A. Jimenez: Noth-
ing to disclose; C. Owens: Nothing to disclose; K.
Seward: Mercator Medsystems,Ownership or Partnership.
PS214.
Aged Rats Have Increased Neointimal Thickening and
Altered MCP-1/CCR2 Expression after Carotid An-
gioplasty
Sammy D. Eghbalieh1, Paraag Chowdhary1, Akihito
Muto2, Jose M. Pimiento1, Fabio A. Kudo2, Kenneth R.
Ziegler2, Yuka Kondo2, Lynn Model2, Alan Dardik2. 1The
Stanley J. Dudrick Department of Surgery, Saint Mary’s
Hospital, Waterbury, CT; 2Yale University School of Med-
icine, New Haven, CT
Objectives: Although carotid angioplasty is associated
with increased adverse events in elderly patients compared
to younger patients, it is unclear whether the response to
carotid angioplasty is also related to the altered inflamma-
tory axis of elderly patients. Therefore we examined the
response to carotid angioplasty as well as the expression of
inflammatory cells, in a validated animal model.
Methods: The right common carotid artery of young
adult (6 month) or aged (22-24 month) male Fischer 344
rats was injured with a balloon and the ipsilateral external
carotid was ligated; common carotid arteries were exam-
ined after 3 and 14 days. Serum monocytes, and expression af carotidMCP-1 and CCR2were examined at 0, 3, and 14
ays.
Results:Aged rats had significantly reduced lumen area
0.180.03 mm2 vs. 0.240.01 mm2; p.02) and in-
reased neointimal thickening (aged: 0.150.04 mm2;
oung: 0.080.03 mm2; p.006) compared with young
dult rats. Aged rats had increased circulating monocytes
95.921.0 vs. 54.06.5; p.0007) at baseline. How-
ver, young rats had increasedMCP-1 after angioplasty but
ged rats did not (day 3: 12.53.0 vs. 8.12.0; n8).
CR2 levels were restored to baseline in young rats but not
n aged rats (day 14: 10.13.6 vs. 1.40.6; n8).
Conclusions: Aged Fischer 344 rats are an accurate
odel for carotid angioplasty in aged humans. Aged rats
lso have altered numbers of circulating monocytes as well
s altered expression of inflammatory cells in post-angio-
lasty carotid arteries, suggesting a role for these cells in the
esponse to carotid angioplasty.
uthor Disclosures: P. Chowdhary: Nothing to disclose;
. Dardik: Nothing to disclose; S. D. Eghbalieh: Nothing
o disclose; Y. Kondo: Nothing to disclose; F. A. Kudo:
othing to disclose; L. Model: Nothing to disclose; A.
uto: Nothing to disclose; J. M. Pimiento: Nothing to
isclose; K. R. Ziegler: Nothing to disclose.
S216.
rolonged versus Standard Balloon Angioplasty Infla-
ion Time in an Atherosclerotic Rat Aorta Model
eva Boone, Gary S. Schwartz, George Jour, John C.
antis. St. Luke’s Roosevelt Hospital Center, New York,
Y
Objectives: The ideal balloon inflation time in balloon
ngioplasty remains unknown. There are theoretical bene-
ts for a prolonged inflation time, including reduced inti-
al trauma and recoil, but studies have been inconclusive.
ur research aims to compare prolonged and standard
nflation time in a rat aortic angioplasty model.
Methods: Male Wistar rats were given Vitamin D3 and
icotine, a regimen previously found to produce arterio-
clerosis in rats, and fed an atherogenic diet with added
holesterol and cholate. After two months, each rat re-
eived distal aortic angioplasty with a 2mm x 8mm standard
ngioplasty balloon at nominal pressure. Inflation was held
or either 30 seconds (standard time) or three minutes
prolonged time). The rats were sacrificed at 24 hours (six
ats, three per time group) or 30 days (ten rats, five per
roup), and aortas were assessed histologically, with com-
arison of intimal disruption in the 24-hour group and
omparison of lumen and wall areas, amount of intimal
yperplasia and medial thickening in the 30-day group.
Results: After 24 hours, both inflation time groups
howed mild intimal disruption, but the difference in wall
isruption scores was not significant. At 30 days, lumen and
uter wall diameters were, respectively, 1.20/0.07mm
nd 1.41 /0.05mm in the 30-second time group, and
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June Supplement 201186S Abstracts1.05 /0.11mm and 1.24 /0.09mm in the 3-min-
ute time group (p NS between groups). Intimal hyperplasia
was modest in all rats, with no significant differences in
intimal wall areas. The intimal and medial wall area as a
percentage of overall vessel area was 35.0 /5.2% in the
30-second group and 36.8 /6.6% in the 3-minute
group (p NS).
Conclusions: Prolonged balloon inflation time failed
to produce significant changes in intimal disruption after
24 hours. At 30 days, there was no difference in the amount
of intimal hyperplasia, medial wall thickening, or lumen
diameter compared to standard inflation times. These re-
sults do not support changing current balloon angioplasty
practices.
Author Disclosures: D. Boone: Nothing to disclose; G.
Jour: Nothing to disclose; J. C. Lantis: Nothing to dis-
close; G. S. Schwartz: Nothing to disclose.
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PS218.
Inhibition of CXCL4-CCL5 Chemokine Interaction
Ameliorates the Development of Abdominal Aortic
Aneurysm in Mice
Yasunori Iida1, Baohui Xu1, Joshua Schultz2, Court R.
Turner2, Ronald L. Dalman1. 1Vascular Surgery, Stanford
University School of Medicine, Stanford, CA; 2Carolus
Therapeutics, Inc., La Jolla, CA
Objectives: Abdominal aortic aneurysm (AAA) is a
macrophages-driven vascular disease. Given the importance
of CXCL4-CCL5 chemokine interaction in macrophage/
monocytes migration into inflamed arteries, we evaluated
the effect of a novel synthetic peptide inhibitor to CXCL4-
CCL5 interaction on AAA progression in the porcine pan-
creatic elastase (PPE)-induced AAA mouse model.
Methods: AAA was created in 10-wk-old male
C57BL/6 mice by PPE infusion into infrarenal aorta.
These mice were injected i.v. with the synthetic peptide
inhibitor to CXCL4-CCL5 interaction (CT-2009ca, 10
(n5) or 20 (n7) mg/kg/day or the vehicle (n8)
(Carolus Therapeutics, Inc) for 3 days before PPE infusion
and 13 days thereafter. The AAA was imaged by ultra-
sonography and defined as a 50% increase in the aortic
diameter. The aortae were harvested 14 days after PPE
infusion and subjected to histopathology.
Results: AAA developed in all mice treated with the
vehicle within 7 days. In contrast, AAA developed in 3mice
and 1 mouse treated with the CT-2009ca at the dose of 10
and 20 mg /kg/day, respectively, within 14 days. The
CT-2009ca treatment dose-dependently inhibited the
PPE-induced increase in aorta diameter. Moreover, the
elastic Masson staining and the anti-smooth muscle cell
alpha actin antibody immunostaining revealed that medial
elastin fibers and smooth muscle cell layers were well pre-
served in the CT-2009ca-treated mice as compared to the
vehicle-treated mice. As expected, the CT-2009ca treat- sent significantly reduced the numbers of macrophages,
D4 T cells and neutrophils and newly formed blood
essels in the media and adventitia by immunostaining with
he mAbs against leukocyte subsets and endothelial cells.
Conclusions: In the mouse PPE model of AAA, inhi-
ition of CXCL4-CCL5 interaction by CT-2009ca sup-
ressed AAA development by reducing angiogenesis and
imitingmedial and adventitial infiltration of certain subsets
f leukocytes. Thus, CT-2009ca may be a potential thera-
eutic candidate for treating human AAA disease.
uthor Disclosures: R. L. Dalman: Nothing to disclose;
. Iida: Nothing to disclose; J. Schultz: Nothing to dis-
lose; C. R. Turner: Nothing to disclose; B. Xu: Nothing
o disclose.
S220.
hermo-Mechanical Resistance of a Nanocomposite
olymer Exposed to Simulated in Vivo Hydrodynamic
atigue for Ten Years in Development of a Sutureless
ndovascular Stent Graft
ital Y. Desai1, Raheleh Bakhshi2, Arnold Darbyshire2,
ax Ahmed2, James Eaton-Evans3, Xiang Zhou3, Zhong
ou3, AlexanderM. Seifalian2, GeorgeHamilton1. 1Vascu-
ar Surgery, Royal Free Hampstead NHS Trust, London,
nited Kingdom; 2Division of Surgery and Interventional
cience, University College London, London, United
ingdom; 3Department of Engineering Science, Univer-
ity of Oxford, Oxford, United Kingdom
Objectives: To physiologically test thermo-mechanical
esistance of a nanocomposite polymer based on polyhedral
ligomeric silsesquioxane (POSS) and poly (carbonate-
rea) urethane (PCU) to assess its feasibility as graft mate-
ial for a sutureless aortic stent-graft by exposing it to
imulated in vivo hydrodynamic fatigue according to FDA
uidelines.
Methods: Aortic stent-grafts (n4) were tested in 37
egree Celsius distilled water using in vitro accelerated
ircumferential pulsatile model. After analysis for 400-mil-
ion cycles equivalent to 10-years in human body, the
echanical and elastic properties were determined by Fou-
ier transform infrared spectroscopy (FTIR), radial stress-
train studies, and linear elasticity tests. Dynamic scanning
alorimetry (DSC) and Thermo-mechanical analysis
TMA) were used to assess thermal resistance. Comparison
as made with zero-cycled control.
Results: All stent-grafts (n4; diameter 250.1 mm;
ength 25.30.5 cm) successfully completed accelerated
ulsatile fatigue testing at 37°C and pulse pressure 9414
m Hg over 12 months. FTIR showed increased intensity
f -NHCO- bonds (62% transmittance in tested specimen
ompared to 47% in control) but there was no difference in
ntensity of other major bonds and no significant sign of
egradation. Tensile strain of fatigue-tested polymer com-
ared favourably with zero-cycled control at 50% to 500%
tress (P0.69). When stretched up to 500% original
